BMRN | BioMarin Pharmaceutical Inc
Category: Consumer goods
Quick infos Headquarters: Novato, California, United States Trade prices Volume: Market Cap: 14.88B Prev closed: 75.1 Open: 74.79 High: 76.53 Low: 74.6 52 week low: 71.35 52 week high: 121.23 Dividends: No Dividends Next ER: April 27, 2022 After Market Closes
About the Company BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies.
Earnings History Date EPS / Forecast Revenue / Forecast August 4, 2022 April 27, 2022 0.63 / 0.2024519.36M / 511.08MBeat! February 23, 2022 -0.32 / -0.3625449.81M / 442.38MBeat! October 27, 2021 -0.2 / -0.2481408.74M / 435.3MJuly 28, 2021 0.07 / -0.1091501.7M / 448.31MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Apr 29, 2022 81.35 81.47 83.61
81.24
1.46M -1.56% Apr 28, 2022 82.64 83.79 84.29
78.95
2.20M 2.90% Apr 27, 2022 80.31 79.94 81.15
79.50
1.11M 1.29% Apr 26, 2022 79.29 80.97 81.95
79.28
918.52K -3.16% Apr 25, 2022 81.88 82.18 82.74
80.74
1.10M 1.71% Apr 22, 2022 80.50 80.15 81.01
79.97
919.51K 0% Apr 21, 2022 80.50 81.20 82.08
80.05
799.92K -0.14% Apr 20, 2022 80.61 80.52 81.42
79.67
1.24M 0.04% Apr 19, 2022 80.58 81.61 82.19
80.47
1.07M -0.74% Apr 18, 2022 81.18 81.91 82.14
80.49
992.03K -2.13% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:March 1997 Employees:2,849 News
LAWSUITS FILED AGAINST BMRN, LSPD and SNAP - Jakubowitz Law Pursues Shareholders Claims finance.yahoo.com Nov 22, 2021 10:00 pm
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the Firm finance.yahoo.com Nov 22, 2021 9:00 pm
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the Firm finance.yahoo.com Nov 22, 2021 9:00 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadline BMRN finance.yahoo.com Nov 22, 2021 7:20 pm
BioMarin Shareholder Notice finance.yahoo.com Nov 22, 2021 6:42 pm
BioMarin Shareholder Alert finance.yahoo.com Nov 22, 2021 6:42 pm
BioMarin Shareholder Alert finance.yahoo.com Nov 22, 2021 6:15 pm
BioMarin says ex-employee downloaded trade secrets. He says it's a misunderstanding. bizjournals.com Nov 22, 2021 5:54 pm BioMarin Stock Jumps As FDA Approval Unlocks Its 'Next Growth Inflection' investors.com Nov 22, 2021 4:23 pm
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HEPS, BMRN and HMLP finance.yahoo.com Nov 22, 2021 3:55 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadline BMRN finance.yahoo.com Nov 22, 2021 3:23 pm
INVESTOR REMINDER: BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SHAREHOLDER CLASS ACTION DEADLINE- Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc. finance.yahoo.com Nov 22, 2021 1:15 pm
FDA Conditionally Approves Biomarin's Dwarfism Drug finance.yahoo.com Nov 22, 2021 12:38 pm
BioMarin Pharmaceutical Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against BioMarin Pharmaceutical Inc. finance.yahoo.com Nov 22, 2021 11:33 am
BioMarin wins FDA approval of drug to treat dwarfism in kids bizjournals.com Nov 22, 2021 11:03 am
BioMarin Shareholder Alert finance.yahoo.com Nov 22, 2021 6:08 pm
BioMarin Deadline Alert finance.yahoo.com Nov 22, 2021 6:02 pm
BMRN EQUITY NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with LARGE LOSSES to Secure Counsel Before Important Deadline in Class Action - BMRN finance.yahoo.com Nov 22, 2021 3:30 pm
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Nov 22, 2021 3:10 pm
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Nov 22, 2021 3:08 pm This company doesn't provide a dividend.
Key Persons CEO : Jean-Jacques Bienaime (May 2005–) Talk about BioMarin Pharmaceutical Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
